The global hyaluronic acid products market is expected to grow at a CAGR of around 7.2% during the forecast period of 2023-2030 and is estimated at US$ 2.9 billion in 2023.
Products using hyaluronic acid (HA) as the active ingredient fall within the categories of skincare and pharmaceuticals. The human body naturally has hyaluronic acid, mostly found in the skin, joints, and connective tissues. It is a well-known component in many products for its moisturizing and anti-aging benefits because of its capacity to draw in and hold moisture.
Increasingly, people are looking for skincare and anti-aging products that may hydrate their skin, make it look plumper, and lessen the appearance of fine lines and wrinkles. Hyaluronic acid is popular in moisturizers, serums, and other skincare products due to its capacity to draw and hold moisture.
Rising Demand for Natural and Clean Beauty Products Driving Hyaluronic Acid Products Market
The market for hyaluronic acid (HA) products is expanding significantly because of the growing desire for natural and healthy beauty products. Customers are increasingly looking for goods that have just natural ingredients and no additives that could be hazardous. Being a naturally occurring chemical in the human body, hyaluronic acid fits very well with these desires.
The long-term effects and potential adverse effects of synthetic or chemically generated chemicals, frequently found in skincare and beauty products, are coming to consumers’ attention. They are therefore actively looking for all-natural alternatives, such as hyaluronic acid.
Request for Sample and Scope of the Study
North America Significantly Drives Global Hyaluronic Acid Products Market Growth
A dominating market for HA Products is North America. The region has a developed skincare market and a large number of consumers who are aware of skincare and anti-aging goods. Formulations based on HA are popular because of the high demand for natural and healthy beauty products. The popularity of dermal filler operations and medical aesthetics practices also contributes to the market growth of injectable HA products.
Europe is another important market for hyaluronic acid products, with major contributions including the UK, France, and Germany. The demand for hyaluronic acid products is fueled by the region’s significant emphasis on natural and organic skincare. In addition, Europe is renowned for having a thriving medical aesthetics sector with a significant need for hyaluronic acid dermal fillers.
Market Structure and Competitive Landscape
These players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the hyaluronic acid products market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global hyaluronic acid products market include,
- In February 2022, AbbVie Inc received approval from the Food and Drug Administration for JUVEDERM VOLBELLA XC, which can treat infraorbital hollows in individuals over the age of 21. In the US market, this increased the company’s aesthetic product line.
- In August 2021, HyLink was introduced by Saikagaku Corporation, a pharmaceutical manufacturing business with headquarters in Japan, to treat knee osteoarthritis. HyLink is a Visco supplement for the treatment of osteoarthritis of the knee that is injected once into the joint.
- In May 2021, Sinclair Pharma, a UK-based pharmaceutical business introduced MaiLi, using hyaluronic acid a new facial filler.
- The first OxiFree technology, which shields lengthy hyaluronic acid molecule chains, has been granted a patent. While volume is intended to enhance volume to the face and inject fat beneath the skin, the defined product is aimed to address deep wrinkles and increase lip volume.
The global hyaluronic acid products market is fragmented in nature with the presence of various players operating in the market. Some of the prominent players operating in the hyaluronic acid products market include BASF SE, Allergan Inc, Zimmer Inc, Koninklijke DSM N.V., Sinclair Pharma Limited, Teva Pharmaceutical Industries Ltd, Kewpie Corporation, Seikagaku Corporation, Galderma SA, Lifecore Biomedical Inc, Contipro a.s., HTL Biotechnology others.
Key Market Segmentation
RationalStat has segmented the global hyaluronic acid products market based on product, application, distribution channel, and region.
- By Product
- Single Cycle Injection Products
- Three Cycle Injection Products
- Five Cycle Injection Products
- By Application
- Osteoarthritis
- Ophthalmic
- Dermal Fillers
- Vesicoureteral Reflux
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Specialty Clinics
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
To customize reports as per your needs, speak to our analyst
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for manufacturers, raw material suppliers, third-party distributors, construction industry players, government organizations, research institutes, educational organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global hyaluronic acid products market is anticipated to grow at a CAGR of approximately 7.2% during the forecast period 2023-2030.
The global hyaluronic acid products market is estimated at US$ 2.9 billion in 2023.
Rising demand for natural and clean beauty products driving the global hyaluronic acid products market.
North America holds the major share of the global hyaluronic acid products market.
Leading Companies operating in the global hyaluronic acid products market include BASF SE, Allergan Inc, Zimmer Inc, Koninklijke DSM N.V., Sinclair Pharma Limited, Teva Pharmaceutical Industries Ltd, Kewpie Corporation, Seikagaku Corporation, Galderma SA, Lifecore Biomedical Inc, Contipro a.s., HTL Biotechnology etc.